FDA panel to re-examine wrinkle-fighting injection labels

November 17, 2008 9:13:43 AM PST
Some wrinkle-fighting injections may be getting stricter warning labels. U.S. regulators have received reports of serious and unexpected problems in people treated with wrinkle-fighting injections known as dermal fillers.

The Food and Drug Administration says the problems included facial palsy, disfigurement, swelling, and severe allergic reactions. The agency said it received a total of 930 reports of health problems over the past six years.

Dermal fillers include such products as Juvederm, Restylane, Perlane, and Radiesse. However, the FDA did not identify which products had reports of more serious problems.

Tuesday, the FDA will ask a panel of outside experts whether labels for those products should be changed. The makers of the dermal fillers insist their products are safe.


Load Comments